Skip to main content

Peer Review reports

From: Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors

Original Submission
16 Jul 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
6 Oct 2023 Reviewed Reviewer Report
30 Oct 2023 Reviewed Reviewer Report
1 Dec 2023 Author responded Author comments - Jing Wang
Resubmission - Version 3
1 Dec 2023 Submitted Manuscript version 3
3 Dec 2023 Reviewed Reviewer Report
11 Dec 2023 Reviewed Reviewer Report
13 Dec 2023 Author responded Author comments - Jing Wang
Resubmission - Version 4
13 Dec 2023 Submitted Manuscript version 4
4 Jan 2024 Author responded Author comments - Jing Wang
Resubmission - Version 5
4 Jan 2024 Submitted Manuscript version 5
6 Jan 2024 Author responded Author comments - Jing Wang
Resubmission - Version 6
6 Jan 2024 Submitted Manuscript version 6
Publishing
8 Jan 2024 Editorially accepted
24 Jan 2024 Article published 10.1186/s12865-024-00599-y

You can find further information about peer review here.

Back to article page